Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXC.L Regulatory News (MXC)

  • There is currently no data for MXC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MGC Pharmaceuticals delivers its largest-ever order

8 Dec 2022 13:47

MGC Pharmaceuticals Ltd MGC Pharmaceuticals delivers its largest-ever order 08.12.2022 / 14:46 CET/CEST The issuer is solely responsible for the content of this announcement.


Contact Details

Proactive

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

News Source: News Direct

08.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com


Language:English
Company:MGC Pharmaceuticals Ltd
United States
ISIN:AU000000MXC6
EQS News ID:1508695
 
End of NewsEQS News Service

1508695 08.12.2022 CET/CEST

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
28th Sep 20224:35 pmRNSPrice Monitoring Extension
28th Sep 20227:00 amRNSContravention of the TGA Advertising Code
23rd Sep 20227:00 amRNSUS$550,000 funding received under Mercer Facility
21st Sep 20227:00 amRNSCimetrA™ Dose Finding Study Interim Results
8th Sep 202212:47 pmRNSWebsite / Social Media update
6th Sep 202211:30 amRNSDispatch of General Meeting Documents
1st Sep 20227:00 amRNSPreliminary Financial Report for 30 June 2022
25th Aug 20227:00 amRNSFinal Payment for Malta GMP Manufacturing Plant
17th Aug 20227:00 amRNSAMC Holdings, Inc. places US$1M ArtemiC™ order
15th Aug 20227:00 amRNSCannEpil® Clinical Study on Driving Performance
11th Aug 202211:05 amRNSSecond Price Monitoring Extn
11th Aug 202211:00 amRNSPrice Monitoring Extension
8th Aug 202210:30 amRNSUpdated Investor Presentation
3rd Aug 20227:00 amRNSFirst Tranche of Mercer Street Funding Received
29th Jul 20227:00 amRNSUS$10m Financing Agreement with Mercer Street
28th Jul 20227:45 amRNSPurchase of Strategic 40% Stake in AI Software
25th Jul 20227:00 amRNSJune Quarterly Activities Report and Cash Flow
19th Jul 20227:00 amRNSChief Commercial Officer Appointment
14th Jul 20224:41 pmRNSSecond Price Monitoring Extn
14th Jul 20224:36 pmRNSPrice Monitoring Extension
14th Jul 20222:05 pmRNSSecond Price Monitoring Extn
14th Jul 20222:00 pmRNSPrice Monitoring Extension
14th Jul 202211:05 amRNSSecond Price Monitoring Extn
14th Jul 202211:00 amRNSPrice Monitoring Extension
14th Jul 20229:05 amRNSSecond Price Monitoring Extn
14th Jul 20229:00 amRNSPrice Monitoring Extension
14th Jul 20227:16 amRNSClinical Study results - patients with Long COVID
8th Jul 20227:00 amRNSApproval Granted for CimetrA Dose Finding Study
6th Jul 20228:00 amRNSLaunch of ZAM - Medical data App
27th Jun 20227:00 amRNSCimetrATM Pre-clinical Trial Progress Report
24th Jun 20227:00 amRNSUSA Market Update: CimetrA Clinical Trial Progress
16th Jun 20227:00 amRNSSuccessful Glioblastoma Pre-clinical Trial Results
6th Jun 20227:00 amRNSCogniCann© Phase II Clinical Trial Results
27th May 20221:08 pmRNSCompliance Filing of UK subsidiary FY21 Accounts
23rd May 202210:43 amRNSApplication for Admission to Trading
20th May 20227:00 amRNSAcademic Paper on Effect of ArtemiC™ Published
18th May 202212:06 pmRNSDirector/PDMR Shareholding
10th May 20227:01 amRNSCannEpil® Drug Delivery System Patent Approval
9th May 202212:28 pmRNSDirector/PDMR Shareholding
6th May 20223:08 pmRNSReplacement: Director/PDMR Shareholding
5th May 202211:10 amRNSDirector/PDMR Shareholding
4th May 20227:00 amRNSPartnership with HempStreet
29th Apr 20224:41 pmRNSSecond Price Monitoring Extn
29th Apr 20224:35 pmRNSPrice Monitoring Extension
29th Apr 202210:03 amRNSMarch Quarterly Activities Report and Cash Flow
26th Apr 20227:00 amRNSAppointment of new Chief Financial Officer
25th Apr 202211:08 amRNSApplication for Admission to Trading
21st Apr 20227:00 amRNSCimetrA™ Patent Approved by European IP Office
12th Apr 20228:36 amRNSPerformance Rights and Change of CFO
7th Apr 202210:35 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.